Celso Arango

Celso Arango (Palma de Mallorca 1968- ) is a psychiatrist who has worked extensively as a clinician, researcher, and educator in psychiatry and mental health, notably in the field of child and adolescent psychiatry, psychosis, and mental health promotion. As a result of this work, Dr. Arango has received national and international recognition with the most prestigious awards and distinctions in the field of psychiatry.

Biography

Dr. Arango is currently Head of the Child and Adolescent Psychiatry Service, which includes the Psychiatry Department’s Adolescent Psychiatry Unit at Hospital General Universitario Gregorio Marañón, Professor of Psychiatry [1] at Universidad Complutense of Madrid, Adjunct Professor of Psychiatry[2] at the University of Maryland, a Visiting Professor of Psychiatry[3] at King's College London and Full Adjunt Professor of Psychiatry[4] at University of California, San Francisco (UCSF).

From 2008 to 2016, he was the Scientific Director of the Spanish Psychiatric Research Network (CIBERSAM).[5] Also in 2008, the Spanish Ministry of Health, Social Services, and Equality awarded him its Medal of Honor, the “Cruz de la Orden Civil de Sanidad.[6] Between 2012 and 2014, he was the Fundación Alicia Koplowitz Endowed Chair for Child Psychiatry at the Universidad Complutense of Madrid, and he has been a board member[7] of the European Brain Council (the European Commission's advisory body) since 2013. In December 2014, he was appointed Chairman of the National Commission for the Child and Adolescent Psychiatry Specialty by the Ministry of Health, Social Services and Equality. Recently he was awarded by The American College of Psychiatrists with the Dean Award.

Dr. Arango has been past President[8] of The European College of Neuropsychopharmacology (ECNP), and lately September, he was appointed as President[9] of the Spanish Psychiatry Society. Dr. Arango has written numerous articles that have been published in journals such as Nature, British Journal of Psychiatry, Archives of General Psychiatry, Biological Psychiatry, World Psychiatry, and American Journal of Psychiatry.

Selected publications

Dr. Arango has written more than 450 peer-reviewed articles, including:

  • Rees et al. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia. Nature Neuroscience. 2020 Feb;23(2):179-184.
  • Guloksuz et al. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. World Psychiatry. 2019 Jun;18(2):173-182.
  • Arango et al. Preventive strategies for mental health. Lancet Psychiatry. 2018 Jul;5(7):591-604.
  • Lim et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nature Neuroscience. 2017 Sep;20(9):1217-1224.
  • Galling et al. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2016 Mar;73(3):247-59.
  • Vorstman JA, et al. Deletion Syndrome. Cognitive Decline Preceding the Onset of Psychosis in Patients with 22q11.2 Deletion Syndrome. JAMA Psychiatry. 2015 Apr;72(4):377-85.
  • Steinberg S, et al. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry. 2014 Jan;19(1):108-14.
  • Arango C. Child neuropsychopharmacology: good news… the glass is half full. World Psychiatry. 2013 Jun;12(2):128-9.
  • Arango C et al. Progressive brain changes in children and adolescents with first-episode psychosis. JAMA Psychiatry. 2012 Jan; 69(1):16-26.
  • Steinberg S et al. Common Variants at VRK2 and TCF4 Conferring Risk of Schizophrenia. Hum Mol Genet. 2011 Oct; 20(20):4076-81.
  • Arango C et al. Lessons learned about poor insight. Schizophr Bull. 2011 Jan; 37(1):27-8.
  • Arango C. Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2011 Feb; 20(2): 67-70.
  • Janssen J et al. Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biol Psychiatry. 2009 Dec 1;66(11):1047-54.
  • Vitiello B et al. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol. 2009 Sep;19(9):629-35.

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.